Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1

Status

Recruiting 4Unknown 3Completed 2Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Epstein-Barr Virus Infections 2Cytomegalovirus Infections 2Adenoviridae Infections 2Immunologic Deficiency Syndromes 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 332Specimen Handling 331Radiotherapy 315Cyclophosphamide 298pembrolizumab 286Cisplatin 270Carboplatin 247Drug Therapy 238Blood Specimen Collection 234Biopsy 203Bevacizumab 185Gemcitabine 181venetoclax 177Radiosurgery 170Oxaliplatin 164Capecitabine 163fludarabine 161Paclitaxel 158Nivolumab 157Standard of Care 135Surveys and Questionnaires 132Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 123Rituximab 113Docetaxel 112tislelizumab 111Cytarabine 106toripalimab 101Radiation 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × OTHER × Cell Count × Clear all
NCT07330050 2026-01-09

WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
31 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07144735 2025-08-27

ABOUT

Peking University Third Hospital

Phase NA Recruiting
18 enrolled
CNS

Glioblastoma

NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Columbia University

Phase 1 Recruiting
18 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

NCT05183490 2024-12-30

R-MVST Cells for Treatment of Viral Infections

Columbia University

Phase 1 Recruiting
36 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡